November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Amol Akhade about the role of CAR-T in solid tumors
Nov 14, 2024, 13:29

Amol Akhade about the role of CAR-T in solid tumors

Amol Akhade, Senior consultant medical oncologist and hemato-oncologist at Suyog Cancer Clinics and Reliance Hospitals, shared a post on LinkedIn:

“There is lot of buzz about role of CAR-T in solid tumors .

Nice review published in Nature Biotech. Go through the table showing responses of the recently published data . Note the number of pts in each trial ( some have pts in single digits ) and response rates. No one talks about duration of response. Most needed more than One infusion. Most needed something else along with CAR-T.

Let’s hold our excitement and expectations from CAR-T in solid tumors . It is still more of ” hit or miss ” therapy in solid tumors .
And don’t try it outside clinical trials .

I feel it is just a bubble. Bispecific drugs or may be mRNA Vaccines will win the race over CAR-T.

Remember, we used to do autologous bone marrow transplant for metastatic breast cancer with similar excitement once ( in 1994 )
And we all know where it went from there.”

Amol Akhade about the role of CAR-T in solid tumors

Dr. Amol Akhade is a senior consultant medical oncologist and hemato-oncologist. He has received his super specialization training in hemato-oncology and medical oncology from Tata Memorial Hospital. He specialises in chemotherapy for hematological cancers as well as solid tumors. He also specialises in allogenic and autologous bone marrow transplant. Currently, he is a Consultant Medical Oncologist at Suyog Cancer Clinics and Reliance Hospitals.